Abstract
The aim of the present study was to investigate, whether concomitant administration of the synthetic glucocorticoid betamethasone (BM), theophylline (THEO), or the muscarinic antagonist ipratropium bromide (IPRA) could influence the desensitization‐associated decrease of β‐adrenoceptors in the guinea pig lung during prolongedin vivotreatment with the β2‐agonist terbutaline (TER). The animals were sacrificed 20 hrs after the last drug dosage and the lung membrane homogenates were prepared for3H‐dihydroalprenolol (3H‐DHA) bindingin vitro.Treatment with TER 200 µg/kg subcutaneously twice a day for five days decreased by 22% the maximum number of binding sites (Bmax) at saturation in comparison with the saline‐treated controls. Concomitant administration of BM 2 mg/kg intraperitoneally abolished this effect of TER, whereas THEO 20 mg/kg or IPRA 5 µg/kg failed to modify it. None of thein vivotreatments affected the binding affinity of3H‐DHA.In vitro,TER inhibited in a concentration‐dependent manner3H‐DHA binding to the lung membranes of untreated guinea pigs. At high concentrations IPRA, but not THEO or BM, showed some binding to the β‐receptors as well. Thus, it is concluded that glucocorticoids may prevent β‐adrenoceptor desensitization in the lungs via an indirect mechanism, e.g. inhibition of phospholipase A2enzyme.